Wikidata

(Q39976180)

English

Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development

scientific article

In more languages

Statements

title
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18519791
retrieved
16 September 2017
author name string
Melissa A Tran
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18519791
retrieved
16 September 2017
Charles D Smith
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18519791
retrieved
16 September 2017
Gavin P Robertson
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
18519791
retrieved
16 September 2017
publication date
1 June 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18519791
retrieved
16 September 2017
page(s)
3571-3581
1 reference
stated in
Europe PubMed Central
PubMed ID
18519791
retrieved
16 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39976180&oldid=1881650193"